Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.

Saved in:
Bibliographic Details
Title: Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
Authors: Church RJ; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, NC.; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC., Kullak-Ublick GA; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Switzerland.; Mechanistic Safety, Novartis Global Drug Development, Basel, Switzerland., Aubrecht J; Drug Safety R&D, Pfizer Inc., Groton, CT., Bonkovsky HL; Wake Forest University School of Medicine, Winston-Salem, NC., Chalasani N; School of Medicine, Indiana University, Indianapolis, IN., Fontana RJ; University of Michigan, Ann Arbor, MI., Goepfert JC; Natural and Medical Sciences Institute, Reutlingen, Germany., Hackman F; Pfizer Inc, New York, NY., King NMP; Predictive Safety Testing Consortium, Tucson, AZ., Kirby S; Pfizer Inc, New York, NY., Kirby P; Takeda Pharmaceuticals, Deerfield, IL., Marcinak J; Takeda Pharmaceuticals, Deerfield, IL., Ormarsdottir S; Global Patient Safety, AstraZeneca R&D, Gothenburg, Sweden., Schomaker SJ; Drug Safety R&D, Pfizer Inc., Groton, CT., Schuppe-Koistinen I; Science for Life Laboratory, Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden., Wolenski F; Takeda Pharmaceuticals, Deerfield, IL., Arber N; Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel., Merz M; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, University of Zurich, Switzerland.; Discovery and Investigative Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland., Sauer JM; Predictive Safety Testing Consortium, Tucson, AZ., Andrade RJ; Unidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Málaga, Spain., van Bömmel F; Section of Hepatology, Clinic of Gastroenterology and Hepatology, University Hospital Leipzig, Leipzig, Germany., Poynard T; Department of Hepatology, Groupe Hospitalier Pitié Salpêtrière, University Pierre et Marie Curie, INSERM UMR 938, Paris, France., Watkins PB; Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, NC.; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC.
Source: Hepatology (Baltimore, Md.) [Hepatology] 2019 Feb; Vol. 69 (2), pp. 760-773. Date of Electronic Publication: 2018 Jun 27.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3350
DOI:10.1002/hep.29802